• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of immune escape in different digestive tumours.免疫逃逸在不同消化系统肿瘤中的作用。
World J Clin Cases. 2021 Dec 6;9(34):10438-10450. doi: 10.12998/wjcc.v9.i34.10438.
2
Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.免疫肿瘤学:了解免疫系统在癌症中的功能和失调。
Ann Oncol. 2012 Sep;23 Suppl 8(Suppl 8):viii6-9. doi: 10.1093/annonc/mds256.
3
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
4
Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.HPV16相关肿瘤的免疫逃逸表型:MHC I类分子表达在进展和治疗过程中的变化
Int J Oncol. 2005 Feb;26(2):521-7.
5
Immune Landscape of Thyroid Cancers: New Insights.甲状腺癌的免疫全景:新的见解。
Front Endocrinol (Lausanne). 2021 Apr 27;11:637826. doi: 10.3389/fendo.2020.637826. eCollection 2020.
6
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).免疫逃避 PD-L1/PD-1 阻断:成功(或失败)的七个步骤。
Ann Oncol. 2016 Aug;27(8):1492-504. doi: 10.1093/annonc/mdw217. Epub 2016 May 20.
7
Chimeric Antigen Receptors for the Tumour Microenvironment.嵌合抗原受体靶向肿瘤微环境
Adv Exp Med Biol. 2020;1263:117-143. doi: 10.1007/978-3-030-44518-8_8.
8
Natural killer group 2D receptor and its ligands in cancer immune escape.自然杀伤细胞组 2D 受体及其配体在癌症免疫逃逸中的作用。
Mol Cancer. 2019 Feb 27;18(1):29. doi: 10.1186/s12943-019-0956-8.
9
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation.HLA介导的肿瘤逃逸机制可能通过T细胞激活损害免疫治疗的临床疗效。
Oncol Lett. 2017 Oct;14(4):4415-4427. doi: 10.3892/ol.2017.6784. Epub 2017 Aug 21.
10
Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy.肿瘤细胞降低 T 细胞中的线粒体活性,从而逃避 PD-1 阻断疗法。
Elife. 2020 Mar 3;9:e52330. doi: 10.7554/eLife.52330.

引用本文的文献

1
Application of Bioinformatics in Predicting the Efficacy of Digestive Tumour Immunotherapy Target TIM-3 and its Inhibitors.生物信息学在预测消化肿瘤免疫治疗靶点TIM-3及其抑制剂疗效中的应用
J Cancer. 2024 Feb 12;15(7):1954-1965. doi: 10.7150/jca.92446. eCollection 2024.
2
A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.基于外泌体相关免疫抑制基因与肝癌肿瘤微环境的综合研究。
BMC Cancer. 2022 Dec 22;22(1):1344. doi: 10.1186/s12885-022-10463-0.

本文引用的文献

1
Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK.积雪草苷通过阻断p65和p38丝裂原活化蛋白激酶(p38MAPK)的激活来抑制胰腺癌PANC-1细胞的上皮-间质转化和干细胞样特性。
J Gastrointest Oncol. 2021 Feb;12(1):196-206. doi: 10.21037/jgo-20-533.
2
Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression.TGF-β 在胰腺导管腺癌进展和 PD-L1 表达中的作用。
Cell Oncol (Dordr). 2021 Jun;44(3):673-687. doi: 10.1007/s13402-021-00594-0. Epub 2021 Mar 10.
3
miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway.miR-146b-5p 通过核因子-κB 通路靶向 Toll 样受体 4 抑制胆囊癌的发生和转移。
Oncol Rep. 2021 Apr;45(4). doi: 10.3892/or.2021.7966. Epub 2021 Mar 2.
4
The Roles of circRNAs in Liver Cancer Immunity.环状RNA在肝癌免疫中的作用
Front Oncol. 2021 Feb 4;10:598464. doi: 10.3389/fonc.2020.598464. eCollection 2020.
5
Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling.敲低微管相关丝氨酸/苏氨酸激酶样蛋白表达通过激活ERK1/2和使NF-κB信号失活来抑制胃癌细胞生长并诱导凋亡。
Curr Med Sci. 2021 Feb;41(1):108-117. doi: 10.1007/s11596-021-2325-2. Epub 2021 Feb 13.
6
Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.基于肿瘤微环境的中药与抗肿瘤治疗联合策略的研究现状及分子机制。
Front Immunol. 2021 Jan 21;11:609705. doi: 10.3389/fimmu.2020.609705. eCollection 2020.
7
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target.肝癌中的 MDSCs:关键的肿瘤促进因子和潜在的治疗靶点。
Cell Immunol. 2021 Mar;361:104295. doi: 10.1016/j.cellimm.2021.104295. Epub 2021 Jan 21.
8
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.结直肠癌中 HLA I 类分子的缺失:免疫逃逸和免疫治疗的意义。
Cell Mol Immunol. 2021 Mar;18(3):556-565. doi: 10.1038/s41423-021-00634-7. Epub 2021 Jan 20.
9
The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells.HLA-G在肿瘤逃逸中的作用:调控免疫细胞的表型和功能
Front Oncol. 2020 Dec 23;10:597468. doi: 10.3389/fonc.2020.597468. eCollection 2020.
10
Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development.炎症与细胞黏附分子功能的关联对胃肠道癌症发展的影响。
Cells. 2021 Jan 4;10(1):67. doi: 10.3390/cells10010067.

免疫逃逸在不同消化系统肿瘤中的作用。

Role of immune escape in different digestive tumours.

作者信息

Du Xin-Zhu, Wen Bin, Liu Lin, Wei Ying-Ting, Zhao Kui

机构信息

Department of Gastroenterology, The Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.

出版信息

World J Clin Cases. 2021 Dec 6;9(34):10438-10450. doi: 10.12998/wjcc.v9.i34.10438.

DOI:10.12998/wjcc.v9.i34.10438
PMID:35004976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8686128/
Abstract

A counterbalance between immune cells and tumour cells is key to fighting tumours, and immune escape is an important mechanism for the survival of tumour cells in the body. Tumor cells and their cytokines impair the activity of T cells, NK cells, macrophages and other immune cells through various ways, and change the expression of their own surface antigens so as to avoid the clearance of the immune system. Changes in major histocompatibility complex molecules, high expression of programmed death-ligand 1, and the presence of immunosuppressive cells in the tumor microenvironment (TME) are main means by which tumors impair the function of immune cells. During the development of tumours of the digestive system, different mechanisms acting on tumour cells, the TME, and immune cells lead to immune escape and promote tumour progression. In this paper, the mechanisms of immune escape in tumour cells of the digestive system are reviewed to provide a theoretical basis for the immunotherapy of gastrointestinal tumours.

摘要

免疫细胞与肿瘤细胞之间的平衡是对抗肿瘤的关键,而免疫逃逸是肿瘤细胞在体内存活的重要机制。肿瘤细胞及其细胞因子通过多种方式损害T细胞、NK细胞、巨噬细胞等免疫细胞的活性,并改变自身表面抗原的表达,从而逃避免疫系统的清除。主要组织相容性复合体分子的变化、程序性死亡配体1的高表达以及肿瘤微环境(TME)中免疫抑制细胞的存在是肿瘤损害免疫细胞功能的主要手段。在消化系统肿瘤的发生发展过程中,作用于肿瘤细胞、TME和免疫细胞的不同机制导致免疫逃逸并促进肿瘤进展。本文综述了消化系统肿瘤细胞免疫逃逸的机制,为胃肠道肿瘤的免疫治疗提供理论依据。